Sawaya M C, Horton R W, Meldrum B S
Department of Neurology, Institute of Psychiatry, De Crespigny Park, London,l England.
Epilepsia. 1975 Nov;16(4):649-55. doi: 10.1111/j.1528-1157.1975.tb04747.x.
The effect of anticonvulsant drugs on the activity of enzymes responsible for the further metabolism of GABA has been studied in mouse brain homogenates. Slight inhibition (5 to 20%) of GABA-T activity was seen with chlordiazepoxide (0.1 mM), ethosuximide (0.1 mM) and di-n-propylacetate (0.1 mM). No anticonvulsant drug (even at a concentration of 10 mM) produced inhibition comparable to that seen with amino-oxyacetic acid (65% at 0.01 mM). Succinic semialdehyde dehydrogenase activity was inhibited by 10 to 20% at low concentrations (0.01 to 0.1 mM) of diazepam, carbamazepine, beclamide, acetazolamide, and di-n-propylacetate, and by 40% or more at high concentrations (2.5 to 10.0 mM) of diazepam, phenobarbital, carbamazepine, beclamide, and di-n-propylacetate. Interference with the further metabolism of GABA may contribute to the antiepileptic action of drugs or to the acute neurological toxicity of anticonvulsant agents.
在小鼠脑匀浆中研究了抗惊厥药物对负责γ-氨基丁酸(GABA)进一步代谢的酶活性的影响。氯氮卓(0.1 mM)、乙琥胺(0.1 mM)和二正丙基乙酸酯(0.1 mM)可使GABA转氨酶(GABA-T)活性轻微抑制(5%至20%)。没有一种抗惊厥药物(即使浓度为10 mM)产生的抑制作用能与氨氧基乙酸(0.01 mM时为65%)相比。在低浓度(0.01至0.1 mM)的地西泮、卡马西平、贝克拉胺、乙酰唑胺和二正丙基乙酸酯作用下,琥珀酸半醛脱氢酶活性被抑制10%至20%,而在高浓度(2.5至10.0 mM)的地西泮、苯巴比妥、卡马西平、贝克拉胺和二正丙基乙酸酯作用下,该酶活性被抑制40%或更多。干扰GABA的进一步代谢可能有助于药物的抗癫痫作用或抗惊厥药物的急性神经毒性。